![Chris Packard's highlights from 2022](https://www.triglycerideforum.org/wp-content/uploads/2023/01/chris-packard-video-500x281.jpg)
Chris Packard’s hopes for 2023
Chris Packard, Professor of Vascular Biochemistry at the University of Glasgow, UK, looks forward to fresh insights into the contrasting results of the REDUCE-IT and PROMINENT trials and the impact of changes in triglyceride-rich lipoproteins on atherosclerosis.